Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Obesity | Review

Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success

Authors: Carolyn Ee, Stephanie Pirotta, Aya Mousa, Lisa Moran, Siew Lim

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 13 % of women. Lifestyle interventions are first-line treatments, however attrition in women with PCOS is high. This review summarises current evidence on barriers to lifestyle management in PCOS and suggested strategies for overcoming these challenges, mapped to the Capability, Opportunity, Motivation and Behaviour model.
Physical capability for lifestyle changes may be impacted by altered gut hormone regulation and energy expenditure in PCOS. This may contribute to difficulties with weight management. The higher prevalence of eating disorders, disordered eating, fatigue and sleep disturbances are further barriers. Psychological capability may be reduced due psychological symptoms and lack of critical health literacy. Women with PCOS face similar challenges in terms of Opportunity to make lifestyle changes as other women of reproductive age. However, these are complicated by features more common in PCOS including body dissatisfaction. Motivation to adopt healthy lifestyles may be impacted by suboptimal risk perception and intrinsic motivation.
To address these barriers, screening for and management of eating disorders, disordered eating, depression, and Obstructive Sleep Apnoea should be undertaken as per international evidence-based guidelines. A weight-neutral approach may be appropriate with disordered eating. Building capability among health professionals to better partner with women with PCOS on their management is essential in addressing health literacy gaps. Behavioural strategies that target risk perception and build intrinsic motivation should be utilised. More research is required to understand optimal self-management strategies, risk perception, energy homeostasis and overcoming attrition in women with PCOS.
Literature
1.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.PubMedPubMedCentralCrossRef
2.
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55.PubMedCrossRef
3.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.CrossRef
4.
Karjula S, Morin-Papunen L, Franks S, Auvinen J, Järvelin M-R, Tapanainen JS, Jokelainen J, Miettunen J, Piltonen TT. Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms. J Clin Endocrinol Metab. 2020;105(6):1814–26.PubMedCentralCrossRef
5.
Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26(9):2442–51.PubMedCrossRef
6.
de Groot PCM, Dekkers OM, Romijn JA, Dieben SWM, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495–500.PubMedCrossRef
7.
Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777–84.PubMedCrossRef
8.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526–32.PubMedCrossRef
9.
Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109.PubMedCrossRef
10.
Teede HJ, Costello MF, Dokras A, Laven J, Misso M, Moran LJ, Piltonen T, Norman RJ. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-1618.
11.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with Polycystic Ovary Syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526–32.PubMedCrossRef
12.
Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3:Cd007506.PubMed
13.
Thomson ZO, Kelly JT, Sainsbury A, Reeves MM. Weight loss outcomes in premenopausal versus postmenopausal women during behavioral weight loss interventions: a systematic review and meta-analysis. Menopause. 2020;28(3):337–46.PubMedCrossRef
14.
Lim S, Smith CA, Costello MF, MacMillan F, Moran L, Ee C. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study. BMC Endocr Disord. 2019;19(1):106.PubMedPubMedCentralCrossRef
15.
Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Sci. 2011;6(1):42.CrossRef
16.
Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. Great Britain: Silverback Publishing; 2014.
17.
Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care. 1988;11(7):567–573.
18.
Welle S, Nair KS, Lockwood D. Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus. J Clin Endocrinol Metab. 1988;66(3):593–7.PubMedCrossRef
19.
Franssila-Kallunki A, Groop L. Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(10):962–6.PubMedCrossRef
20.
Ryan M, Livingstone MB, Ducluzeau PH, Salle A, Genaitay M, Ritz P. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain? Diabetes Care. 2008;31(3):448–50.PubMedCrossRef
21.
Carlson MG, Campbell PJ. Intensive insulin therapy and weight gain in IDDM. Diabetes. 1993;42(12):1700–7.PubMedCrossRef
22.
23.
Felig P. Insulin is the mediator of feeding-related thermogenesis: insulin resistance and/or deficiency results in a thermogenic defect which contributes to the pathogenesis of obesity. Clin Physiol. 1984;4(4):267–73.PubMedCrossRef
24.
25.
Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, Kourounis G, Markou KB, Kyriazopoulou V. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril. 2009;92(1):250–5.PubMedCrossRef
26.
Robinson S, Chan SP, Spacey S, Anyaoku V, Johnston DG, Franks S. Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol. 1992;36(6):537–43.CrossRef
27.
Segal KR, Dunaif A. Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes. 1990;14(7):559–67.PubMed
28.
Churchill SJ, Wang ET, Bhasin G, Alexander C, Bresee C, Pall M, Azziz R, Mathur R, Pisarska MD. Basal metabolic rate in women with PCOS compared to eumenorrheic controls. Clin Endocrinol. 2015;83(3):384–8.CrossRef
29.
Romualdi D, Versace V, Tagliaferri V, De Cicco S, Immediata V, Apa R, Guido M, Lanzone A. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study. J Endocrinol Invest. 2019;42(9):1089–97.PubMedCrossRef
30.
Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(2):628–34.PubMed
31.
Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol. 1990;259(5 Pt 1):E650-657.PubMed
32.
Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord. 1992;16(9):667–74.PubMed
33.
Larsson I, Hulthen L, Landen M, Palsson E, Janson P, Stener-Victorin E. Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome. Clin Nutr. 2016;35(1):213–8.PubMedCrossRef
34.
Rimmer M, Tan BK, Teede H, Thangaratinam S, B HAW. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review. Gynecol Endocrinol. 2020;36(6):501–7.PubMedCrossRef
35.
Gao T, Wu L, Chang F, Cao G. Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocr J. 2016;63(1):93–100.PubMedCrossRef
36.
O’Reilly MW, Kempegowda P, Walsh M, Taylor AE, Manolopoulos KN, Allwood JW, Semple RK, Hebenstreit D, Dunn WB, Tomlinson JW, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(9):3327–39.PubMedPubMedCentralCrossRef
37.
Hirschberg AL, Naessen S, Stridsberg M, Bystrom B, Holtet J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol. 2004;19(2):79–87.PubMedCrossRef
38.
Lin T, Li S, Xu H, Zhou H, Feng R, Liu W, Sun Y, Ma J. Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study. Hum Reprod. 2015;30(11):2639–44.PubMedCrossRef
39.
Aydin K, Arusoglu G, Koksal G, Cinar N, Aksoy DY, Yildiz BO. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome. Clin Endocrinol. 2014;81(4):588–92.CrossRef
40.
Moran LJ, Noakes M, Clifton PM, Wittert G, Tomlinson L, Galletly C, Luscombe N, Norman RJ. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Asia Pac J Clin Nutr. 2003;12:S52.
41.
Japur CC, Diez-Garcia RW, de Oliveira Penaforte FR, das Gracas Pena G, de Araujo LB, de Sa MFS. Insulin, ghrelin and early return of hunger in women with obesity and polycystic ovary syndrome. Physiol Behav. 2019;206:252-258.
42.
Moran LJ, Noakes M, Clifton PM, Wittert GA, Le Roux CW, Ghatei MA, Bloom SR, Norman RJ. Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr. 2007;86(6):1603–10.PubMedCrossRef
43.
Daghestani MH, Daghestani M, Daghistani M, El-Mazny A, Bjorklund G, Chirumbolo S, Al Saggaf SH, Warsy A. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Lipids Health Dis. 2018;17(1):195.PubMedPubMedCentralCrossRef
44.
Arusoglu G, Koksal G, Cinar N, Tapan S, Aksoy DY, Yildiz BO. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive. J Clin Endocrinol Metab. 2013;98(11):4475–82.PubMedCrossRef
45.
Alsaadi HM, Van Vugt DA. Insulin sensitivity affects corticolimbic brain responses to visual food cues in polycystic ovary syndrome patients. Horm Mol Biol Clin Invest. 2015;24(2):101–15.
46.
Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, Epperson N, Teede H. Androgen excess- polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888–99.PubMedCrossRef
47.
Jeanes YM, Reeves S, Gibson EL, Piggott C, May VA, Hart KH. Binge eating behaviours and food cravings in women with Polycystic Ovary Syndrome. Appetite. 2017;109:24–32.PubMedCrossRef
48.
Lee I, Cooney LG, Saini S, Sammel MD, Allison KC, Dokras A. Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis. Eat Weight Disord Stud Anorexia Bulimia Obes. 2019;24:787–97.
49.
Tay CT, Teede HJ, Hill B, Loxton D, Joham AE. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study. Fertil Steril. 2019;112(2):353–61.PubMedCrossRef
50.
Naessén S, Söderqvist G, Carlström K. So similar and so different: circulating androgens and androgen origin in bulimic women. J Steroid Biochem Mol Biol. 2018;185:184–88.
51.
Michelmore KF, Balen AH, Dunger DB. Polycystic ovaries and eating disorders: are they related? Hum Reprod. 2001;16(4):765–9.PubMedCrossRef
52.
Larsson I, Hulthén L, Landén M, Pålsson E, Janson P, Stener-Victorin E. Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome. Clin Nutr. 2016;35(1):213–8.PubMedCrossRef
53.
Karacan E, Caglar GS, Gürsoy AY, Yilmaz MB. Body satisfaction and eating attitudes among girls and young women with and without Polycystic Ovary Syndrome. J Pediatr Adolesc Gynecol. 2014;27(2):72–7.PubMedCrossRef
54.
Batcheller AE, Ressler IB, Sroga JM, Martinez AM, Thomas MA, DiPaola KB. Binge eating disorder in the infertile polycystic ovary syndrome patient. Fertil Steril. 2013;100(3):S413.CrossRef
55.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33. quiz 34-57.
56.
Fairburn C, Cooper Z, O’Connor M. Eating disorder examination. In: Fairburn CG, editor. Cognitive behavior therapy and eating disorders. 16th ed. New York: Guildford Press; 2008.
57.
Pirotta S, Barillaro M, Brennan L, Grassi A, Jeanes YM, Joham AE, Kulkarni J, Couch LM, Lim SS, Moran LJ. Disordered eating behaviours and eating disorders in women in Australia with and without Polycystic Ovary Syndrome: a cross-sectional study. J Clin Med. 2019;8:1682–94.
58.
(NEDC) NEDC. Eating disorders prevention, treatment and management an updated evidence review. Sydney: NEDC; 2017.
59.
Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369–76.PubMedCrossRef
60.
Azizi Kutenaee M, Amirjani S, Asemi Z, Taghavi SA, Allan H, Kamalnadian SN, Khashavi Z, Bazarganipour F. The impact of depression, self-esteem, and body image on sleep quality in patients with PCOS: a cross-sectional study. Sleep Breath. 2020;24(3):1027–34.PubMedCrossRef
61.
Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad MH, Javed Chattha A. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Clin Endocrinol. 2020;92(4):338–49.CrossRef
62.
Kahal H, Kyrou I, Uthman OA, Brown A, Johnson S, Wall PDH, Metcalfe A, Parr DG, Tahrani AA, Randeva HS. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24(1):339–50.PubMedCrossRef
63.
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, Hamilton GS, Dharmage SC. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70–81.CrossRef
64.
Moran LJ, March WA, Whitrow MJ, Giles LC, Davies MJ, Moore VM. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum Reprod. 2015;30(2):466–72.PubMedCrossRef
65.
Mo L, Mansfield DR, Joham A, Cain SW, Bennett C, Blumfield M, Teede H, Moran LJ. Sleep disturbances in women with and without polycystic ovary syndrome in an Australian National Cohort. Clin Endocrinol. 2019;90(4):570–8.CrossRef
66.
Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep. 2018;10:45–64.PubMedPubMedCentralCrossRef
67.
Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, Epperson N, Teede H. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril. 2018;109(5):888–99.PubMedCrossRef
68.
Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018;62(2):318–25.PubMedCrossRef
69.
Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–91.PubMedCrossRef
70.
Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–91.PubMedCrossRef
71.
Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010;94(5):1565–74.PubMedPubMedCentralCrossRef
72.
Banting LK, Gibson-Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51.PubMedPubMedCentralCrossRef
73.
Ekramzadeh M, Hajivandi L, Noroozi M, Mostafavi F. Psychological experiences of adolescent girls with Polycystic Ovary Syndrome: a qualitative study. Iran J Nurs Midwifery Res. 2020;25(4):341–7.PubMedPubMedCentralCrossRef
74.
Pastore LM, Patrie JT, Morris WL, Dalal P, Bray MJ. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. J Psychosom Res. 2011;71(4):270–6.PubMedPubMedCentralCrossRef
75.
Alur-Gupta S, Chemerinski A, Liu C, Lipson J, Allison K, Sammel MD, Dokras A. Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil Steril. 2019;112(5):930-938.e931.CrossRef
76.
Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006;11(4):613–25.PubMedCrossRef
77.
Baumeister RF, Vohs KD. Handbook of self-regulation: research, theory, and applications. The Guilford Press. New York; 2004.
78.
Burman JT, Green CD, Shanker S. On the meanings of self-regulation: digital humanities in service of conceptual clarity. Child Dev. 2015;86(5):1507–21.PubMedCrossRef
79.
Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7.CrossRef
80.
Corbin JM, Strauss A. Unending work and care: managing chronic illness at home. San Francisco: Jossey-Bass; 1988.
81.
Ryan P, Sawin KJ. The individual and family self-management theory: background and perspectives on context, process, and outcomes. Nurs Outlook. 2009;57(4):217-225.e216.PubMedPubMedCentralCrossRef
82.
Marks R, Allegrante JP. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (Part II). Health Promot Pract. 2005;6(2):148–56.PubMedCrossRef
83.
Dineen-Griffin S, Garcia-Cardenas V, Williams K, Benrimoj SI. Helping patients help themselves: a systematic review of self-management support strategies in primary health care practice. PLoS One. 2019;14(8):e0220116.PubMedPubMedCentralCrossRef
84.
85.
Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155(2):97–107.PubMedCrossRef
86.
Cheng Y-L, Shu J-H, Hsu H-C, Liang Y, Chou R-H, Hsu P-F, Wang Y-J, Ding Y-Z, Liou T-L, Wang Y-W, et al. High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial.(Research Article). PloS one. 2018;13(3):e0194813.PubMedPubMedCentralCrossRef
87.
Cheong SM, Mohamad Nor NS, Ahmad MH, Manickam M, Ambak R, Shahrir SN, Aris T. Improvement of health literacy and intervention measurements among low socio-economic status women: findings from the MyBFF@home study. BMC Womens Health. 2018;18(1):99.PubMedPubMedCentralCrossRef
88.
Abdollahi M, Peyman N. The effect of an educational program based on health literacy strategies on physical activity in postpartum women. J Midwifery Reprod Health. 2017;5(4):1059–65.
89.
Al-Ruthia YS, Balkhi B, AlGhadeer S, Mansy W, AlSanawi H, AlGasem R, AlMutairi L, Sales I. Relationship between health literacy and body mass index among Arab women with polycystic ovary syndrome. Saudi Pharm J. 2017;25(7):1015–8.PubMedPubMedCentralCrossRef
90.
Lim S, Smith CA, Costello MF, MacMillan F, Moran L, Teede H, Ee C. Health literacy needs in weight management of women with Polycystic Ovary Syndrome. Health Promot J Austr. 2020;32(S1):41–48.
91.
Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15(3):259-267.
92.
Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155(2):97–107.PubMedCrossRef
93.
Moran LJ, Brown WJ, McNaughton SA, Joham AE, Teede HJ. Weight management practices associated with PCOS and their relationships with diet and physical activity. Hum Reprod. 2017;32(3):669–78.PubMed
94.
Humphreys L, Costarelli V. Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome. J R Soc Promot Health. 2008;128(4):190–5.PubMedCrossRef
95.
Jeanes YM, Barr S, Smith K, Hart KH. Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians. J Hum Nutr Diet. 2009;22(6):551–8.PubMedCrossRef
96.
Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol. 2009;28(6):690–701.PubMedCrossRef
97.
Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ). BMC Public Health. 2013;13:658.PubMedPubMedCentralCrossRef
98.
Avery JC, Braunack-Mayer AJ. The information needs of women diagnosed with Polycystic Ovarian Syndrome--implications for treatment and health outcomes. BMC Womens Health. 2007;7:9.PubMedPubMedCentralCrossRef
99.
Bazarganipour F, Taghavi SA, Allan H, Hosseini N. Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: a qualitative study. Int J Reprod Biomed. 2017;15(9):553–60.PubMedPubMedCentral
100.
Crete J, Adamshick P. Managing polycystic ovary syndrome: what our patients are telling us. J Holist Nurs. 2011;29(4):256–66.PubMedCrossRef
101.
Avery J, Ottey S, Morman R, Cree-Green M, Gibson-Helm M. Polycystic ovary syndrome support groups and their role in awareness, advocacy and peer support: a systematic search and narrative review. Curr Opin Endocr Metab Res. 2020;12:98–104.CrossRef
102.
Ee C, Smith C, Moran L, MacMillan F, Costello M, Baylock B, Teede H. "The whole package deal”: experiences of overweight/obese women living with polycystic ovary syndrome. BMC Womens Health. 2020;20(1):221.PubMedPubMedCentralCrossRef
103.
104.
105.
Garad R, McPhee C, Chai TL, Moran L, O’Reilly S, Lim S. The role of health literacy in postpartum weight, diet, and physical activity. J Clin Med. 2020;9(8):1–14.
106.
Andajani-Sutjahjo S, Ball K, Warren N, Inglis V, Crawford D. Perceived personal, social and environmental barriers to weight maintenance among young women: a community survey. Int J Behav Nutr Phys Act. 2004;1(1):15.PubMedPubMedCentralCrossRef
107.
Adamson L, Brown W, Byles J, Chojenta C, Dobson A, Fitzgerald D, Hockey R, Loxton D, Powers J, Spallek M, et al. Women’s weight: findings from the Australian Longitudinal Study on Women’s Health. In. Edited by Ageing AGDoHa. 2007.
108.
Lim S, Smith CA, Costello MF, MacMillan F, Moran L, Ee C. Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: a qualitative study. BMC Endocr Disord. 2019;19(1):106.PubMedPubMedCentralCrossRef
109.
Inouye J. Risk perception: theories, strategies and next steps. In. Edited by Council NS. Itasca: Campbell Institute; 2014.
110.
DiLorenzo TA, Schnur J, Montgomery GH, Erblich J, Winkel G, Bovbjerg DH. A model of disease-specific worry in heritable disease: the influence of family history, perceived risk and worry about other illnesses. J Behav Med. 2006;29(1):37–49.PubMedCrossRef
111.
Erblich J, Bovbjerg DH, Norman C, Valdimarsdottir HB, Montgomery GH. It won’t happen to me: lower perception of heart disease risk among women with family histories of breast cancer. Prev Med. 2000;31(6):714–21.PubMedCrossRef
112.
Kozica SL, Gibson-Helm ME, Teede HJ, Moran LJ. Assessing self-efficacy and self-help methods in women with and without polycystic ovary syndrome. Behav Med. 2013;39(3):90–6.PubMedCrossRef
113.
Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol. 2010;31(1):24–31.PubMedCrossRef
114.
Colwell K, Lujan ME, Lawson KL, Pierson RA, Chizen DR. Women’s perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices. J Obstet Gynaecol Can. 2010;32(5):453–9.PubMedCrossRef
115.
Humphreys L, Costarelli V. Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome. J R Soc Promot Health. 2008;128(4):190–5.PubMedCrossRef
116.
Lin AW, Dollahite JS, Sobal J, Lujan ME. Health-related knowledge, beliefs and self-efficacy in women with polycystic ovary syndrome. Hum Reprod. 2018;33(1):91–100.PubMedCrossRef
117.
Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, Ranasinha S, Teede HJ, Moran LJ. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455–67.PubMedCrossRef
118.
Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339-352.
119.
Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol. 2005;62(3):289–95.CrossRef
120.
Jeanes Y, Barr S, Smith K, Hart K. Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians. J Hum Nutr Diet. 2009;22(6):551–8.PubMedCrossRef
121.
Thomson RL, Buckley JD, Brinkworth GD. Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial. BMC Womens Health. 2016;16:14–14.PubMedPubMedCentralCrossRef
122.
Teixeira PJ, Going SB, Houtkooper LB, Cussler EC, Metcalfe LL, Blew RM, Sardinha LB, Lohman TG. Pretreatment predictors of attrition and successful weight management in women. Int J Obes. 2004;28(9):1124–33.CrossRef
123.
Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;16(2):Cd007506.
124.
Moran LJ, Noakes M, Clifton P, Buckley J, Brinkworth G, Thomson R, Norman RJ. Predictors of lifestyle intervention attrition or weight loss success in women with polycystic ovary syndrome who are overweight or obese. Nutrients. 2019;11(3):1–13.
125.
Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;16(2):Cd007506.
126.
Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020;10(1):7802.PubMedPubMedCentralCrossRef
127.
Finley CE, Barlow CE, Greenway FL, Rock CL, Rolls BJ, Blair SN. Retention rates and weight loss in a commercial weight loss program. Int J Obes (Lond). 2007;31(2):292–8.CrossRef
128.
De Panfilis C, Torre M, Cero S, Salvatore P, Dall’Aglio E, Marchesi C, Cabrino C, Aprile S, Maggini C. Personality and attrition from behavioral weight-loss treatment for obesity. Gen Hosp Psychiatry. 2008;30(6):515–20.PubMedCrossRef
129.
Greenberg I, Stampfer MJ, Schwarzfuchs D, Shai I. Adherence and success in long-term weight loss diets: the dietary intervention randomized controlled trial (DIRECT). J Am Coll Nutr. 2009;28(2):159–68.PubMedCrossRef
130.
Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5:2048004016633371.PubMedPubMedCentral
131.
Honas JJ, Early JL, Frederickson DD, O’Brien MS. Predictors of attrition in a large clinic-based weight-loss program. Obes Res. 2003;11(7):888–94.PubMedCrossRef
132.
Leung AWY, Chan RSM, Sea MMM, Woo J. An overview of factors associated with adherence to lifestyle modification programs for weight management in adults. Int J Environ Res Public Health. 2017;14(8):922.PubMedCentralCrossRef
133.
Gill RS, Karmali S, Hadi G, Al-Adra DP, Shi X, Birch DW. Predictors of attrition in a multidisciplinary adult weight management clinic. Can J Surg. 2012;55(4):239–43.PubMedPubMedCentralCrossRef
134.
Miller BML, Brennan L. Measuring and reporting attrition from obesity treatment programs: a call to action! Obes Res Clin Pract. 2015;9(3):187–202.PubMedCrossRef
135.
Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485–91.CrossRef
136.
Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, Piltonen T, Norman R, Network obotIP. International evidence- based guideline for the assessment and management of polycystic ovary syndrome. Melbourne: Monash University; 2018.
137.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRef
138.
Mensinger JL, Calogero RM, Stranges S, Tylka TL. A weight-neutral versus weight-loss approach for health promotion in women with high BMI: a randomized-controlled trial. Appetite. 2016;105:364–74.PubMedCrossRef
139.
Dugmore JA, Winten CG, Niven HE, Bauer J. Effects of weight-neutral approaches compared with traditional weight-loss approaches on behavioral, physical, and psychological health outcomes: a systematic review and meta-analysis. Nutr Rev. 2020;78(1):39-55.
140.
Monash University. International evidence based guideline for the assessment and management of polycystic ovary syndrome. Melbourne: Monash University; 2018.
141.
Moradi F, Ghadiri-Anari A, Dehghani A, Reza Vaziri S, Enjezab B. The effectiveness of counseling based on acceptance and commitment therapy on body image and self-esteem in polycystic ovary syndrome: an RCT. Int J Reprod Biomed. 2020;18(4):243–52.
142.
Pirotta S, Joham AJ, Moran LJ, Skouteris H, Lim SS. Implementation of evidence-based PCOS lifestyle management guidelines: perceived barriers and facilitators by consumers using the Theoretical Domains Framework and COM-B Model. Patient Educ Couns. 2021.
143.
Khan NN, Vincent A, Boyle JA, Burggraf M, Pillay M, Teede H, Gibson-Helm M. Development of a question prompt list for women with polycystic ovary syndrome. Fertil Steril. 2018;110(3):514–22.PubMedCrossRef
144.
Xie J, Burstein F, Garad R, Teede HJ, Boyle JA. Personalized mobile tool AskPCOS delivering evidence-based quality information about polycystic ovary syndrome. Semin Reprod Med. 2018;36(1):66–72.PubMedCrossRef
145.
Lombard C, Deeks A, Jolley D, Ball K, Teede H. A low intensity, community based lifestyle programme to prevent weight gain in women with young children: cluster randomised controlled trial. Bmj. 2010;341:c3215.PubMedPubMedCentralCrossRef
146.
American College of Cardiology/American Heart Association Task Force on Practice Guidelines OEP. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S41-410.
147.
Pirotta S, Joham A, Hochberg L, Moran L, Lim S, Hindle A, Brennan L. Strategies to reduce attrition in weight loss interventions: a systematic review and meta-analysis. Obes Rev. 2019;20(10):1400–12.PubMedCrossRef
148.
Ortendahl M. Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manage. 2007;3(6):1175–80.
149.
Ruffault A, Bernier M, Juge N, Fournier JF. Mindfulness may moderate the relationship between intrinsic motivation and physical activity: a cross-sectional study. Mindfulness. 2016;7(2):445–52.CrossRef
150.
Post EP, Cruz M, Harman J. Incentive payments for attendance at appointments for depression among low-income African Americans. Psychiatr Serv. 2006;57(3):414–6.PubMedCrossRef
151.
152.
Laken MP, Ager J. Using incentives to increase participation in prenatal care. Obstet Gynecol. 1995;85(3):326–9.PubMedCrossRef
153.
Paul-Ebhohimhen V, Avenell A. Systematic review of the use of financial incentives in treatments for obesity and overweight. Obes Revi. 2008;9(4):355–67.CrossRef
154.
Jochelson K. Paying the patient: improving health using financial incentives. London: Kings Fund; 2007.
Metadata
Title
Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success
Authors
Carolyn Ee
Stephanie Pirotta
Aya Mousa
Lisa Moran
Siew Lim
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-021-00890-8

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue

Research

Thyrotoxicosis and dilated cardiomyopathy in developing countries

Research

Association between vitamin D and glycaemic parameters in a multi-ethnic cohort of postmenopausal women with type 2 diabetes in Saudi Arabia

Research

Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19

Research article

Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis

Research article

The genomic profiling and MAMLD1 expression in human and canines with Cushing’s disease

Research article

Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits